Amphiphilic growth hormone releasing factor (GRF) analogs: peptide design and biological activity in vivo.
Tou. J S JS; Kaempfe. L A LA; Vineyard. B D BD; Buonomo. F C FC; Della-Fera. M A MA; Baile. C A CA
Key Findings
- Amphiphilic design of GRF(1‑29) improves its ability to stimulate growth hormone release.
- Four new amidated analogs with up to eight amino‑acid substitutions showed significantly higher activity than bovine GRF44‑NH2 in sheep.
- The enhanced activity supports the idea that the peptide’s helical and amphiphilic shape is important for receptor interaction.
Practical Outcomes
- For DIY biohackers, the study suggests that not all GRF‑1‑29 products are equal—those engineered for better amphiphilicity may work more efficiently. While the work was done in sheep and used IV dosing, it hints that next‑generation analogs (e.g., modified sermorelin or CJC‑1295‑type peptides) could offer stronger GH spikes, potentially allowing lower doses or less frequent injections. Keep an eye out for commercially available analogs that claim improved amphiphilic design, but treat the findings as early‑stage and not a ready‑to‑use protocol.
Summary
Scientists tweaked the first 29 building blocks of the natural growth‑hormone‑releasing hormone to make it more water‑friendly on one side and fat‑friendly on the other (amphiphilic). The new versions, with up to eight changes, gave a stronger boost in growth hormone when injected into sheep compared to an older version of the peptide.
Abstract
The first twenty-nine amino acids of human Growth Hormone Releasing Factor (hGRF) possess a distinct amphiphilic character. This is seen as twisted hydrophobic and hydrophilic bands in the helical net projection. Four amidated analogs were designed by optimizing amphiphilic and helical potentials of the native sequence. These designed analogs, with up to eight-amino acid changes, were tested in sheep via intravenous injection. The growth hormone-stimulating activities of the analogs were significantly higher when compared to bovine Growth Hormone Releasing Factor (bGRF44-NH2). This suggests that the amphiphilic conformation of GRF(1-29) is important to the receptor.
Study Information
pubmed
1986
1986-09-14T00:00:00.000Z
10.1016/s0006-291x(86)80056-0